ImmunityBio (IBRX)
NASDAQ:IBRX
Holding IBRX?
Track your performance easily

ImmunityBio (IBRX) Financial Statements

1,149 Followers

ImmunityBio Financial Overview

ImmunityBio's market cap is currently ―. The company's EPS TTM is $-0.934; its P/E ratio is -5.80; ImmunityBio is scheduled to report earnings on August 9, 2023, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.05M$ 40.00K$ 139.00K$ 82.00K$ 41.00K
Gross Profit$ 1.05M$ 40.00K$ 139.00K$ 82.00K$ 41.00K
EBIT$ -65.77M$ -67.16M$ -201.33M$ -60.62M$ -66.97M
EBITDA$ -53.66M$ -56.20M$ -196.76M$ -56.04M$ -48.37M
Net Income Common Stockholders$ -134.56M$ -134.11M$ -233.39M$ -95.58M$ -137.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 217.98M$ 170.50M$ 266.46M$ 189.80M$ 45.95M
Total Assets$ 444.32M$ 400.68M$ 504.45M$ 432.42M$ 291.23M
Total Debt$ 998.94M$ 894.78M$ 882.14M$ 688.99M$ 819.16M
Net Debt$ 780.96M$ 724.29M$ 615.68M$ 499.19M$ 773.20M
Total Liabilities$ 1.14B$ 1.09B$ 1.09B$ 843.06M$ 936.41M
Stockholders Equity$ -698.39M$ -692.01M$ -586.99M$ -411.72M$ -642.12M
Cash Flow-
Free Cash Flow$ -101.07M$ -108.24M$ -123.23M$ -93.08M$ -88.30M
Operating Cash Flow$ -100.35M$ -106.98M$ -115.27M$ -87.40M$ -79.77M
Investing Cash Flow$ -51.49M$ -35.62M$ 2.25M$ -15.63M$ -8.60M
Financing Cash Flow$ 148.89M$ 10.22M$ 200.54M$ 237.50M$ 43.41M
Currency in USD

ImmunityBio Earnings and Revenue History

ImmunityBio Debt to Assets

ImmunityBio Cash Flow

ImmunityBio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis